GlassScriptPhysician profile
Andrew Corrigan
NPI 1386105674
$1,539.20
in general payments reported to CMS, 2019-2025
13 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $250 · 2024: $965 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $402.38 | 2023-2024 | Avvigo Guidance System, Watchman Flx |
| Abiomed | $196.77 | 2024-2025 | Impella |
| Shockwave Medical, INC | $187.44 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $187.08 | 2024-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $150.17 | 2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $119.71 | 2023-2025 | Definity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.01 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $56.67 | 2023-2024 | Andexxa |
| Bayer Healthcare Pharmaceuticals INC. | $45.80 | 2025 | Kerendia |
| Cardiva Medical, INC. | $25.28 | 2023 | Cardiva Vascade 6/7f Vcs |
| Teleflex LLC | $23.40 | 2025 | Chocolate |
| Pfizer INC. | $20.02 | 2025 | |
| Philips North America LLC | $13.47 | 2025 | Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Corrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.